Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Carcinoma, Basal Cell 6Skin Neoplasms 2Keratosis, Actinic 2Squamous Cell Carcinoma of Head and Neck 1Non-melanoma Skin Cancer 1Nevus, Pigmented 1Mouth Neoplasms 1Mouth Diseases 1Mixed Tumor, Malignant 1Melanoma 1Lichen Planus, Oral 1Leukoplakia, Oral 1Keratosis, Seborrheic 1Keratosis 1Graft vs Host Disease 1Disease 1Carcinoma 1Bowen's Disease 1Actinic cheilitis 1

Interventions

pembrolizumab 24Nivolumab 23aldesleukin 21Cyclophosphamide 20Ipilimumab 17Interleukin-2 17fludarabine 15fludarabine phosphate 14cemiplimab 12Radiotherapy 7Fluorouracil 7Biopsy 7dabrafenib 6Surveys and Questionnaires 6Dacarbazine 6trametinib 5binimetinib 5Vemurafenib 5Temozolomide 5Surgical Procedures, Operative 5Sirolimus 5Radiation 5Blood Specimen Collection 5Aminolevulinic Acid 5sonidegib 4encorafenib 4Photochemotherapy 4Mohs Surgery 4HhAntag691 4Educational Status 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Skin Neoplasms × Tomography, Optical Coherence × Dermatologic × Clear all
NCT01662713 2023-03-15

OFDI

Massachusetts General Hospital

Phase NA Completed
10 enrolled
Dermatologic

Skin Neoplasms

NCT00390351 2006-10-19

Investigate the Diagnostic Value and Possibilities of OCT in Non-Melanoma Skin Cancer.

Zealand University Hospital

Unknown
120 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡